LONDON (AP) -- GlaxoSmithKline PLC, the world’s second-largest pharmaceutical company, said Monday that it expects to introduce five new cancer treatments through 2010.The drugs will treat a range of different cancers, including cancer of the cervix, the company said in a statement. The new treatments are cervarix, pazopanib, promacta, rezonic and ofatumumab.
